Coping with Candida infections.
Although Candida spp. exist as normal flora on much of the human body, life-threatening invasive infections by these organisms have increased in recent decades. Candida spp. are now one of the most common causes of nosocomial blood stream infections worldwide, and patients with critical illness or malignant disease demonstrate particular susceptibility. Risk factors are identifiable for virtually all patients who develop invasive candidiasis, and clinicians must maintain vigilance for Candida infections in the appropriate clinical context, given the attributable mortality. This review addresses the clinical and molecular epidemiology of invasive Candida infections, common clinical manifestations, available diagnostic methods, and current recommendations for initial therapy.
Evans
Scott E
SE
Department of Pulmonary Medicine, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1100, Houston, TX 77030, USA. seevans@mdanderson.org
D002177:Candidiasis / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology*; D002405:Catheterization, Central Venous / Q000009:adverse effects; D003428:Cross Infection / Q000453:epidemiology / Q000382:microbiology; D006801:Humans; D007362:Intensive Care Units; D007902:Length of Stay; D008172:Lung Diseases, Fungal / Q000382:microbiology; D017720:Molecular Epidemiology; D011014:Pneumonia / Q000382:microbiology; D012141:Respiratory Tract Infections / Q000382:microbiology; D012307:Risk Factors